What is it about?

Senile plaque has a unique blue autofluroscence. This property was discovered in 1981. However, the exact nature of this blue autofluorescence is not clear. This publication showed that senile plaque blue autofluoresence is likely dervied from the amyloid beta self-oligomers and hetro-oligomers.

Featured Image

Why is it important?

This research explains that amyloid beta peptide homo- or hetro- aggregation intrinsically carries the blue autofluoresence. The Aβ amyloid blue autofluorescence not only labels senile plaques but also illustrates red cell aggregation, hemolysis, cerebral amyloid angiopathy, vascular plaques, vascular adhesions, and microaneurysms.

Perspectives

Our results showed that Alzheimer's disease is a multi-amyloidosis disease with amyloid deposits not only in senile plaques but also in the blood lysates and damaged vascular wall. The unique amyloid beta aggregate blue autofluoresence can be used as a endogeneous tracer of amyloidosis cascades in the Alzheimer's disease

Dr. Hualin Fu
Shanghai Jiao Tong University

Read the Original

This page is a summary of: Aβ-Aggregation-Generated Blue Autofluorescence Illuminates Senile Plaques as well as Complex Blood and Vascular Pathologies in Alzheimer’s Disease, Neuroscience Bulletin, February 2024, Springer Science + Business Media,
DOI: 10.1007/s12264-023-01175-x.
You can read the full text:

Read

Resources

Contributors

The following have contributed to this page